A
BSX icon

Argentarii’s Boston Scientific BSX Stock Holding History

Argentarii’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,022
Closed -$1.57M – 215
2026
Q1 		$1.57M Sell
25,022
-3,631
-13% -$290K 0.55% 38
2025
Q4 		$2.73M Sell
28,653
-160
-0.6% -$15.7K 0.89% 24
2025
Q3 		$2.81M Buy
28,813
+5
+0% +$518 1.12% 21
2025
Q2 		$3.09M Sell
28,808
-2,175
-7% -$220K 1.42% 18
2025
Q1 		$3.13M Buy
30,983
+3,616
+13% +$364K 1.55% 17
2024
Q4 		$2.44M Buy
+27,367
New +$2.41M 1.23% 18

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Argentarii's BSX Position: Q2 2026 in Review

Argentarii sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 25,022 shares — an estimated $1.57M sold.

Argentarii first reported a position in BSX in Q4 2024 and held it in 6 quarters. The position peaked at $3.13M in Q1 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Argentarii reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Argentarii sold 25,022 Boston Scientific shares in Q2 2026, an estimated $1.57M.
  • Argentarii first reported a position in Boston Scientific in Q4 2024 and held it in 6 quarters.
  • Argentarii's Boston Scientific position peaked at $3.13M in Q1 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Argentarii's 13F filing for Q2 2026, filed 12 Aug 2026.